Related Experiment Video

Updated: Aug 9, 2026

Identification of Kinase-substrate Pairs Using High Throughput Screening
11:13

Identification of Kinase-substrate Pairs Using High Throughput Screening

Published on: August 29, 2015

Selective kinase inhibition by exploiting differential pathway sensitivity

Charles Kung1, Denise M Kenski, Kristin Krukenberg

  • 1Chemistry and Chemical Biology Graduate Program, University of California, San Francisco, San Francisco, California 94143, USA.

Chemistry & Biology
|April 25, 2006
PubMed

Insights

Selective targeting of cell signaling pathways is possible. A specific inhibitor showed selective effects on Pho85 signaling over Cdk1, demonstrating a new approach for kinase inhibition strategies.

Area of Science:

  • Cellular biology
  • Biochemistry
  • Molecular pharmacology

Background:

  • Protein kinase inhibitors are designed for high target affinity.
  • Selective targeting of kinase pathways is crucial for therapeutic development.

Purpose of the Study:

  • To investigate if differential inhibitory sensitivity between cyclin-dependent kinases (CDKs) Cdk1 and Pho85 allows selective pathway targeting.
  • To explore the potential of partial inhibition for achieving selective cellular effects.

Main Methods:

  • Utilized the oxindole inhibitor GW297361 to assess cellular responses.
  • Compared in vitro biochemical potency against Cdk1 with cellular effects on Pho85 and Cdk1 pathways.
  • Evaluated the sufficiency of partial inhibition for activating/blocking specific signaling pathways.

Main Results:

  • The inhibitor GW297361 demonstrated a Pho85-selective cellular response despite higher in vitro potency for Cdk1.
  • Partial inhibition of Pho85 was sufficient to activate its dependent signaling.
  • Partial inhibition of Cdk1 did not effectively block Cdk1-dependent cell proliferation.

Conclusions:

  • Differential kinase sensitivity can enable selective pathway perturbation.
  • Identifying highly sensitive kinases offers a complementary strategy to traditional affinity-based targeting for selective kinase inhibition.

More Related Videos

Identification of Novel CK2 Kinase Substrates Using a Versatile Biochemical Approach11:11

Identification of Novel CK2 Kinase Substrates Using a Versatile Biochemical Approach

Published on: February 21, 2019

Kinase Inhibitor Screening In Self-assembled Human Protein Microarrays13:22

Kinase Inhibitor Screening In Self-assembled Human Protein Microarrays

Published on: October 23, 2019

Related Concept Videos

Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...